HomeMDRX • OTCMKTS
Veradigm Inc
$7.70
After Hours:
$7.70
(0.00%)0.00
Closed: Mar 28, 4:07:46 PM GMT-4 · USD · OTCMKTS · Disclaimer
StockUS listed securityUS headquartered
Previous close
$7.80
Day range
$7.45 - $8.00
Year range
$5.01 - $14.09
Market cap
834.67M USD
Avg Volume
7.73M
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD)Sep 2022Y/Y change
Revenue
151.92M
Operating expense
58.24M
Net income
14.53M
Net profit margin
9.56
Earnings per share
0.23-14.81%
EBITDA
39.01M
Effective tax rate
55.94%
Total assets
Total liabilities
(USD)Sep 2022Y/Y change
Cash and short-term investments
492.60M
Total assets
1.69B
Total liabilities
513.64M
Total equity
1.18B
Shares outstanding
109.26M
Price to book
0.72
Return on assets
3.70%
Return on capital
4.48%
Net change in cash
(USD)Sep 2022Y/Y change
Net income
14.53M
Cash from operations
28.14M
Cash from investing
-9.25M
Cash from financing
-38.45M
Net change in cash
-19.57M
Free cash flow
32.45M
About
Veradigm is a publicly traded American company that provides physician practices, hospitals, and other healthcare providers with practice management and electronic health record technology. Veradigm also provides products for patient engagement and care coordination, as well as financial and analytics technology. The company has more than 180,000 physician users and has products in 2,700 hospitals and 13,000 extended care organizations. The company formally changed its name from Allscripts to Veradigm in January 2023. Wikipedia
Founded
1986
Employees
8,000
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu